Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitochondrial disease: mutations and mechanisms.

Matthew McKenzie1, Danae Liolitsa, Michael G Hanna

  • 1Department of Physiology, University College London, Gower Street, London, United Kingdom WC1E 6BT. m.mckenzie@ucl.ac.uk

Neurochemical Research
|March 25, 2004
PubMed
Summary

Mitochondrial diseases stem from mitochondrial DNA (mtDNA) defects, often involving oxidative phosphorylation deficiencies. Emerging research highlights the roles of reactive oxygen species (ROS) and altered apoptosis in disease development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

UCL Queen Square Institute of Neurology: 75 years of innovation.

The Lancet. Neurology·2026
Same author

Emerging therapeutic strategies for mitochondrial DNA-related diseases.

Cell reports. Medicine·2026
Same author

COXFA4L2 upregulation preserves residual cytochrome c oxidase activity in COXFA4-related Leigh-like encephalopathy.

Nature communications·2026
Same author

Mavodelpar in patients with primary mitochondrial myopathy: a phase 1 trial.

Scientific reports·2026
Same author

Ten common mistakes that could ruin your enrichment analysis.

PLoS computational biology·2026
Same author

Phosphate ions reverse the phase composition of silk fibroin condensates.

Materials horizons·2026

Area of Science:

  • Biochemistry
  • Genetics
  • Cell Biology

Background:

  • Mitochondrial diseases are a complex group of disorders with varied clinical presentations.
  • Defects in mitochondrial DNA (mtDNA) are linked to these diseases, with biochemical defects often identifiable.
  • While deficiencies in mitochondrial oxidative phosphorylation are primary pathogenic factors, other mechanisms are increasingly recognized.

Purpose of the Study:

  • To discuss the current understanding of mitochondrial disease pathophysiology.
  • To explore the roles of various contributing mechanisms beyond oxidative phosphorylation defects.

Main Methods:

  • Review of existing literature on mitochondrial diseases.
  • Analysis of studies investigating biochemical defects and genetic associations.

Related Experiment Videos

  • Examination of research on reactive oxygen species (ROS) and apoptosis in disease models.

    • Main Results:

    • Mitochondrial DNA (mtDNA) defects and oxidative phosphorylation deficiencies are key factors.
    • Mitochondrial reactive oxygen species (ROS) generation is implicated in pathogenesis.
    • Altered apoptotic signaling is observed in mitochondrial dysfunction.

    Conclusions:

    • Mitochondrial diseases involve complex pathophysiology with multiple contributing factors.
    • Reactive oxygen species (ROS) and apoptosis play significant roles alongside primary energy metabolism defects.
    • Further research is needed to fully elucidate the interplay of these mechanisms.